ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,670.13
      1.24%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. ASLAN Pharmaceuticals Ltd (ASLN)

      7. ASLAN Pharmaceuticals Ltd (ASLN) News

      ASLN

      ASLAN Pharmaceuticals (ASLN)

      ASLAN Pharmaceuticals Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ASLN
      DateTimeSourceHeadlineSymbolCompany
      03/11/20248:03AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      02/14/20244:45PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      01/24/20247:52AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      01/08/20247:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      12/22/20234:24PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      12/08/20234:42PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      10/27/20238:14AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      10/24/20238:32AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      10/16/20236:08AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      08/18/20237:33AMEdgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      08/11/20237:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      07/20/20237:55AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      07/06/20238:11AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      07/06/20238:09AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      07/06/20237:59AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      07/03/20234:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      04/28/20237:29AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      04/26/20235:27PMEdgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      04/26/20234:28PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      03/24/20237:33AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      03/24/20237:03AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      03/20/20235:21PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      03/10/20237:31AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      03/06/20235:11PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      03/03/20238:31AMEdgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      02/14/20234:02PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      01/04/20236:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      12/21/20226:04AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      11/03/20224:08PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
      11/03/20224:08PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
       Showing the most relevant articles for your search:NASDAQ:ASLN